Short answer
Hims & Hers Health, Inc. (HIMS) filed an 8-K current report with the SEC on August 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results announcement for quarter ended June 30, 2026.
Hims & Hers Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results announcement for quarter ended June 30, 2026
- Press release furnished as Exhibit 99.1, containing the company’s reported financial results
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $753.2M, up 38%, driven by U.S. growth of 16% and international revenue up 1,641%
- Subscribers reached 2.891M, up 19%, while monthly revenue per average subscriber rose 21% to $92
- Profitability deteriorated: gross margin fell to 64% from 76%, net loss reached $86.3M, and Adjusted EBITDA declined to $60.3M
- Full-year guidance raised to $3.1B-$3.3B revenue and $275M-$325M Adjusted EBITDA, implying 9%-10% margin
- Eucalyptus acquisition accelerated international expansion, but acquisition-related obligations and goodwill materially increased balance-sheet leverage
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Hims & Hers Health, Inc. 8-K filings
Get the next HIMS 8-K as it lands
Follow HIMS for push alerts, or ask the research agent what this filing means.